<h4>Introduction</h4>Tumor cells frequently develop immune resistance through interferon-γ (IFN-γ)-induced PD-L1 expression, acquisition of cancer stem cell (CSC)-like features, and adaptation to hypoxia within the tumor microenvironment (TME). This evidence concerns the gene IFNG and cancer.